Acute and Chronic Effect of His-pacing in Consecutive Patients With AV-block

NCT ID: NCT01019213

Last Updated: 2012-05-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-09-30

Study Completion Date

2011-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Conventional right ventricular (RV) apical pacing may result in asynchronous ventricular contraction with delayed left ventricular activation, interventricular motion abnormalities, and worsening of left ventricular ejection fraction. His pacing is preserving a synchronous contraction and may prevent a decrease in left ventricular ejection fraction.

Hypothesis: His-pacing preserves left ventricular function and is a feasable alternative compared to RV septal septal pacing in patients with AV-block.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conventional right ventricular apical pacing may result in asynchronous ventricular contraction with delayed left ventricular activation, interventricular motion abnormalities, and worsening of left ventricular ejection fraction. His pacing is preserving a synchronous contraction and may prevent a decrease in left ventricular ejection fraction.

The aims of our crossover, double-blinded, randomized study is to evaluate the feasibility and long-term safety of permanent His pacing and to compare the effects on left ventricular ejection fraction of permanent His pacing with those of conventional right septal stimulation after 12 months treatment in patients with 2nd or 3rd degree AV-block.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrioventricular Block

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Septal pacing

Septal lead will be activated.

Group Type PLACEBO_COMPARATOR

Septal pacing

Intervention Type OTHER

Septal lead activated

His-pacing

His lead will be activated 80 ms before septal lead

Group Type EXPERIMENTAL

His lead activated

Intervention Type OTHER

His lead will be activated 80 ms before septal lead

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Septal pacing

Septal lead activated

Intervention Type OTHER

His lead activated

His lead will be activated 80 ms before septal lead

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Septal lead His lead

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 2nd or 3rd degree Av block

Exclusion Criteria

* QRS \> or = 120 ms
* Indication for cardiac resynchronization therapy (CRT) or implantable cardioverter defibrillator (ICD)
* chronic atrial fibrillation
* Pregnant
* Expected heart surgery \< 2 years
* Expected survival \> 2 years
* Patients that have been His ablated
* Serious comorbidity
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Danish Heart Foundation

OTHER

Sponsor Role collaborator

Aarhus University Hospital Skejby

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mads Brix Kronborg

Dr.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Torsten T Nielsen, Professor

Role: STUDY_CHAIR

Dept. B Skejby Hospital

Jens C Nielsen, Phycisian

Role: STUDY_CHAIR

Aarhus university Hospital Skajby

Mads B Kronborg, Phycisian

Role: PRINCIPAL_INVESTIGATOR

Aarhus University Hospital Skejby

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dept. of cardiology Skejby Hospital

Aarhus, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

References

Explore related publications, articles, or registry entries linked to this study.

Kronborg MB, Mortensen PT, Poulsen SH, Gerdes JC, Jensen HK, Nielsen JC. His or para-His pacing preserves left ventricular function in atrioventricular block: a double-blind, randomized, crossover study. Europace. 2014 Aug;16(8):1189-96. doi: 10.1093/europace/euu011. Epub 2014 Feb 7.

Reference Type DERIVED
PMID: 24509688 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

07-4-B695-A1464-22378

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pacing in First-degree AV-block
NCT01985802 COMPLETED NA
Short Atrioventricular Delay Pacing
NCT01233661 WITHDRAWN NA